Tenet Healthcare Corp (THC): Today's Featured Health Care Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Tenet Healthcare ( THC) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.5%. By the end of trading, Tenet Healthcare rose 13 cents (2.1%) to $6.31 on average volume. Throughout the day, 9.1 million shares of Tenet Healthcare exchanged hands as compared to its average daily volume of 7.8 million shares. The stock ranged in a price between $6.11-$6.44 after having opened the day at $6.11 as compared to the previous trading day's close of $6.18. Other companies within the Health Care sector that increased today were: Skystar Bio-Pharmaceutical Company ( SKBI), up 19.7%, Spherix ( SPEX), up 17.5%, Savient Pharmaceuticals ( SVNT), up 16.8%, and Prima Biomed Ltd. ADR ( PBMD), up 11.5%.
  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, and related health care facilities in the United States. Tenet Healthcare has a market cap of $2.59 billion and is part of the health services industry. The company has a P/E ratio of 47.8, above the S&P 500 P/E ratio of 17.7. Shares are up 21.1% year to date as of the close of trading on Friday. Currently there are four analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Tenet Healthcare as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, generally high debt management risk, disappointing return on equity and poor profit margins.

On the negative front, Peregrine Pharmaceuticals ( PPHM), down 78.5%, Questcor Pharmaceuticals ( QCOR), down 36.7%, Escalon Medical Corporation ( ESMC), down 23.8%, and Dehaier Medical Systems ( DHRM), down 21.2%, were all laggards within the health care sector with HCA Holdings ( HCA) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.